Tumor anemia and thrombocytosis in patients with vulvar cancer

Tumor Biology

Volumn 21, Issue 5, 2000, Pages 309-314

  Hefler, Lukas ^a   Mayerhofer, Klaus ^b   Leibman, Ben ^a   Obermair, Andreas ^b   Reinthaller, Alexander ^b   Kainz, Christian ^b   Tempfer, Clemens ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anemia; Prognosis; Thrombocytosis; Vulvar cancer

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; CANCER SURVIVAL; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; THROMBOCYTE COUNT; THROMBOCYTOSIS; VULVA CANCER;

EID: 0033839694     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030136     Document Type: Article

References (21)

1. Spivak JL: Cancer-related anemia: Its causes and characteristics. Semin Oncol 1994;21:3-8.
2. Obermaier A, Handisurya A, Kaider A, Sevelda P, Koelbl H, Gitsch G: The relationship of pretreatment serum hemoglobin level to the survival of epithelial ovarian carcinoma patients: A prospective study. Cancer 1998;83:726-731.
3. Werner-Wasik M, Schmid CH, Bornstein L, Ball HG, Smith DM, Madoc-Jones H: Prognostic factors for local and distant recurrence in stage I and II cervical cancar. Int J Radiat Oncol Biol Phys 1995;32:1309-1317.
4. Johnson DW, Cox RS, Billingham G, Ung N, Martinez A: Survival prognostic factors, and relapse patterns in uterine cervical carcinoma. Am J Clin Oncol 1983;6:407-415.
5. Santhosh-Kumar CR, Yohannan MD, Higgy KE, Al-Mashdani SA: Thrombocytosis in adults: Analysis of 777 patients. J Intern Med 1991;229:493-495.
6. Tranum BL, Haut A: Thrombocytosis: platelet kinetics in neoplasia. J Lab Clin Med 1974;84:615-619.
7. Mehta P: Potential role of platelets in the pathogenesis of tumor metastasis. Blood 1984;63:55-63.
8. Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuk A, Synan I, Dodge RK: The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 1994;83:445-448.
9. Gucer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G, Petru E, Winter R: Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 1998;70:210-214.
10. Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM: Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 1994;74:90-92.
11. Zeimet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O: Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994;170:549-554.
12. Kucera H, Weghaupt K: The electrosurgical operation of vulvar carcinoma with postoperative irradiation of inguinal lymph nodes. Gynecol Oncol 1988;29:158-167.
13. Jatzko GR, Lisborg PH, Denk H, Klimpfinger M, Stettner HM: A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer 1995;76:1302-1312.
14. Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC: Preoperative radiotherapy for muscle-invasive bladder carcinoma: Long-term follow-up and prognostic factors for 338 patients. Cancer 1994;74:2819-2827.
15. Dunphy EP, Petersen IA, Cox RS, Bagshaw MA: The influence of initial hemoglobin and blood pressure levels on results of radiation therapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1988;16:1172-1178.
16. Silvis SE, Turbkas N, Doscherholmen A: Thrombocytosis in patients with lung cancer. JAMA 1970;211:1852-1853.
17. Olesen LL, Thorshauge H: Thrombocytosis in patients with malignant pleural mesothelioma. Cancer 1988;62:1194-1196.
18. Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J: Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992;69:2975-2977.
19. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P: Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-4515.
20. Warrell RP Jr, Bockman RS, Staszewski H, Maiese K: Clinical study of a new antimetastatic compound, Natazatrom (Bay g 6575). Effects on platelet consumption and monocyte prostaglandin production in patients with advanced cancer. Cancer 1986;57:1455-1460.
21. Pedersen LM, Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 1996;9:1826-1830.